Medy-Tox Market Cap

Medy-Tox has a market cap or net worth of 880.93 billion as of September 16, 2025. Its market cap has decreased by -34.89% in one year.

Market Cap

880.93B

Enterprise Value

914.86B

Revenue

234.63B

Ranking

n/a

PE Ratio

44.30

Stock Price

125,500.00

Market Cap Chart

Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 880.93B, an increase of 1,128.20%. That is a compound annual growth rate of 16.23%.

Market Cap History

Date	Market Cap	% Change
Sep 15, 2025	885.85B	6.59%
Dec 30, 2024	831.10B	-48.75%
Dec 28, 2023	1,621.72B	101.16%
Dec 29, 2022	806.18B	-7.99%
Dec 30, 2021	876.20B	-13.91%
Dec 30, 2020	1,017.74B	-39.32%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.88T
Celltrion	37.82T
ALTEOGEN	26.27T
Yuhan	8,955.07B
SK Biopharmaceuticals	8,692.77B
Peptron	7,152.29B
PharmaResearch	6,690.93B
ABL Bio	5,746.76B

Market Cap Rankings